BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24992836)

  • 1. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
    Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
    Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
    Ribeiro M; Rosenstock TR; Cunha-Oliveira T; Ferreira IL; Oliveira CR; Rego AC
    Free Radic Biol Med; 2012 Nov; 53(10):1857-67. PubMed ID: 22982598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.
    Naia L; Ribeiro M; Rodrigues J; Duarte AI; Lopes C; Rosenstock TR; Hayden MR; Rego AC
    Neuropeptides; 2016 Aug; 58():73-81. PubMed ID: 26876526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
    Oliveira JM
    J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
    Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
    PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
    Naia L; Ferreira IL; Cunha-Oliveira T; Duarte AI; Ribeiro M; Rosenstock TR; Laço MN; Ribeiro MJ; Oliveira CR; Saudou F; Humbert S; Rego AC
    Mol Neurobiol; 2015 Feb; 51(1):331-48. PubMed ID: 24841383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
    Ribeiro M; Silva AC; Rodrigues J; Naia L; Rego AC
    Toxicol Sci; 2013 Dec; 136(2):487-99. PubMed ID: 24008831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice.
    Ransome MI; Hannan AJ
    Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.
    Li X; Valencia A; Sapp E; Masso N; Alexander J; Reeves P; Kegel KB; Aronin N; Difiglia M
    J Neurosci; 2010 Mar; 30(13):4552-61. PubMed ID: 20357106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.
    Kim DI; Lee KH; Gabr AA; Choi GE; Kim JS; Ko SH; Han HJ
    Biochim Biophys Acta; 2016 Nov; 1863(11):2820-2834. PubMed ID: 27599716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
    Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
    Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells.
    Gines S; Ivanova E; Seong IS; Saura CA; MacDonald ME
    J Biol Chem; 2003 Dec; 278(50):50514-22. PubMed ID: 14522959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells.
    Oliveira AM; Cardoso SM; Ribeiro M; Seixas RS; Silva AM; Rego AC
    Neurochem Int; 2015 Dec; 91():1-12. PubMed ID: 26476055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
    Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
    Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.
    Humbert S; Bryson EA; Cordelières FP; Connors NC; Datta SR; Finkbeiner S; Greenberg ME; Saudou F
    Dev Cell; 2002 Jun; 2(6):831-7. PubMed ID: 12062094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.
    Naia L; Cunha-Oliveira T; Rodrigues J; Rosenstock TR; Oliveira A; Ribeiro M; Carmo C; Oliveira-Sousa SI; Duarte AI; Hayden MR; Rego AC
    J Neurosci; 2017 Mar; 37(10):2776-2794. PubMed ID: 28123081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.
    Valencia A; Sapp E; Kimm JS; McClory H; Reeves PB; Alexander J; Ansong KA; Masso N; Frosch MP; Kegel KB; Li X; DiFiglia M
    Hum Mol Genet; 2013 Mar; 22(6):1112-31. PubMed ID: 23223017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
    Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
    Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.